Supplement reference
CoQ10 (Ubiquinol)
A sourced reference on CoQ10 (Ubiquinol) identity, evidence limits and safety context.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 March 2027.
What it is
Ubiquinol is the reduced form of coenzyme Q10. It should be distinguished from ubiquinone and from a general energy claim.
Sources: National Library of Medicine, PubMed
What the cited evidence shows
A 2026 meta-analysis examined CoQ10 trials for depressive symptoms and fatigue in people with depression or underlying illness. Its population and outcomes do not establish benefit for healthy people, every CoQ10 form, cardiovascular disease or statin symptoms.
Sources: National Library of Medicine, PubMed
Limits and safety context
This reference does not provide a treatment or medicine-adjustment plan.
Sources: National Library of Medicine, PubMed
Published sources
- Coenzyme Q10 and depressive symptoms/fatigue: systematic review and meta-analysis
National Library of Medicine, PubMed. 2026; accessed 6 September 2026.
Supports: Trials in people with depression or underlying illness; not evidence for ubiquinol in healthy people or every CoQ10 form.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.